Packaging services and supplier
- Specialist in complex secondary packaging, not a generic CDMO
- Full service: design, components, assembly, serialisation, GDP-ready shipping
- GMP licensed, FMD compliant, Schedule I and II controlled substances


Specialist service and supplier in one, for the programmes most CDMOs avoid
Most pharma teams do not need another commodity supplier. They need a partner who can translate a demanding brief into a production reality without months of escalation. Ecobliss sits in the segment most suppliers avoid: specialised secondary packaging for orphan drugs, specialty pharma, medical devices and controlled substances. Projects that require engineering input, patient-centric thinking and regulatory discipline, not just throughput.
We have been doing exactly that since 1996 from our facility in Echt, the Netherlands, with 40 specialists who stay on your programme from first prototype to commercial release.

Full secondary scope under one GMP-licensed roof
As a service provider and supplier in one, we cover the full secondary scope around your blister or primary pack. That includes tailor-made wallets, blister cards, cartons, kits, titration packs, inlay cards, multipanel wallets, clinical trial secondary packaging and child-resistant formats through our patented Locked4Kids platform. Medical device secondary packaging, including trays, Tyvek liddings and inlay cards, runs on the same lines. We source and manage the materials, we do not fill primary blisters.
Cold seal is a sealing technique, not a pack format, and roughly 90 percent of our programmes run on it. Water-based, solvent-free adhesive, up to 80 percent lower energy use compared with heat seal, and better patient handling on opening. Combined with FSC certified board (C194323) and artwork managed through our blockchain-protected document system, sustainability is built into the production standard rather than bolted on. Serialisation and aggregation run on every line, so EU FMD, US DSCSA and market-specific variants are handled without disrupting lead time.

Short lines, direct QA access, decisions at project speed
Scalability is where most niche suppliers fail. Ecobliss runs manual and automated lines in the same facility, so a clinical trial batch and a commercial launch can live on the same system without a technology transfer. There is no fixed minimum order quantity. Prototypes are delivered within 5 to 10 working days, a packaging assessment within one week, and our in-house design team supports artwork, proofing and material sourcing from day one.
Short lines, direct QA access and a collaborative culture keep decisions fast. You work with the people who build the pack, not with a broker.
A partner for complex programmes, not commodity throughput
Large CDMOs are built for scale and grow rigid around it. Small suppliers lack the GMP, GDP and FMD infrastructure to support a regulated commercial launch. Ecobliss closes the gap in between. Locked4Kids, our patented child-resistant platform, is proof that we invest in our own IP rather than reselling generic solutions. Schedule I and II controlled substance licences are on site, so tech transfers for sensitive molecules do not stall on paperwork.
We sit strategically in the Netherlands, short travel distance to every major pharma hub in Europe, with established programmes for pharma, biotech and medical device customers on both sides of the Atlantic.
What to expect when you work with Ecobliss
Step 1. Packaging assessment within one week
Share your brief, target markets and regulatory constraints. Within one week you receive a structured assessment covering format options, materials, serialisation setup, sustainability impact and indicative timelines.
Step 2. Prototype in 5 to 10 working days
Our in-house design team builds a functional prototype so you can validate usability, patient handling and artwork before tooling. Iterations are quick because design, production and QA sit in the same building.
Step 3. Clinical to commercial on one system
We run your clinical batches and commercial volumes on the same qualified lines. Manual and automated setups, no fixed minimum order, serialisation and aggregation included as standard, scalable as your programme grows.
Step 4. GMP production and GDP-ready release
GMP licensed manufacturing, FMD compliant serialisation on every line, GDP compliant warehousing and release for EU, US and RoW markets. One partner, one point of accountability, audit-ready documentation.
Ready for a packaging partner who speaks your complexity?
Looking for a secondary pharma packaging partner who can match your complexity without the overhead of a full CDMO? Let us assess your programme and show you what a specialist service and supplier in one can deliver. Call plus 31 475 390 550 or request your packaging assessment.
Frequently asked questions from pharma procurement
Are you a CDMO or a packaging specialist?
We are a specialist in secondary pharmaceutical packaging, service provider and supplier in one. We do not handle API, formulation, primary filling or QP release. What we do extremely well is design, source, produce and serialise complex secondary packaging around your primary pack, at clinical and commercial scale.
What type of programmes fit Ecobliss best?
Complex, high-value, low to mid volume secondary packaging. Orphan drugs, specialty pharma, medical devices, controlled substances, child-resistant formats and patient-centric adherence packs. If your programme needs engineering input and regulatory discipline rather than pure commodity throughput, you are in the right place.
Do you handle serialisation and EU FMD compliance?
Yes. Serialisation and aggregation run on every line. We are fully FMD compliant for the EU and support DSCSA requirements for the US, plus market-specific variants for RoW. This is standard infrastructure, not a separate project.
Is there a minimum order quantity?
No fixed minimum. We run manual and automated lines in the same facility, so clinical trial volumes, niche launches and larger commercial programmes all fit within the same qualified system.
Can you support controlled substances and child-resistant packaging?
Yes. We are licensed for Schedule I and II controlled substances, and our Locked4Kids platform is a patented child-resistant solution certified for both EU and US markets. It is our own IP, so we can adapt the format to your programme.
What is your approach to sustainability?
FSC certified board under licence C194323, water-based solvent-free adhesive for cold seal, and up to 80 percent lower energy use compared with heat seal. Sustainability is built into the production standard, not offered as a premium option.
How do you handle artwork and change control?
Artwork, proofing and material sourcing are managed by our in-house design team, with documents secured in a blockchain-protected management system. Market-specific variants, late-stage changes and regulated change control are part of the standard workflow.


